XCUR
EXICURE, INC.
Key Financials
EPS (Diluted)
$-0.79
↑ 83.4%
Net Income
$-4946000
↑ 49.0%
Total Assets
$14.0M
↓ 6.7%
Revenue
$0
↓ 100.0%
Operating Income
$-4233000
↑ 65.4%
Total Liabilities
$10.1M
↑ 22.1%
Cash & Equivalents
$816000.00
↓ 90.5%
Long-term Debt
$6.9M
↓ 58.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/1/2026 | View on SEC |
| 10-Q | 5/29/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| 8-K | 4/10/2026 | View on SEC |
| 8-K | 4/2/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 10-K | 3/25/2026 | View on SEC |
| 8-K | 3/25/2026 | View on SEC |
| 4 | 2/19/2026 | View on SEC |
| 8-K | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XCUR |
| Company Name | EXICURE, INC. |
| CIK | 1698530 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 847-673-1707 |